FDA Pulls Zantac Off Shelves Over Cancer Connection
Recently the FDA found unacceptable amounts of Nitrosodimethylamine (NDMA) in Zantac. NDMA is considered a probable human carcinogen by both the World Health Organization (WHO), and the U.S. Environmental Protection Agency (EPA).
The FDA permits a daily intake of 96 nanograms of NDMA, but testing revealed each tablet contained over 3,000,000 nanograms. That’s 3,000 times greater than the FDA’s intake limit.
NDMA is a chemical that is traditionally used in rocket fuel, and is used to purposely infect lab animals with cancer for research purposes.